Details of Disease

General Information of Disease (ID: DIS3SD7J)

• Disease Name: Corneal abrasion
• Disease Class: NA06: Eye/orbit injury
• Disease Hierarchy:
  DIS01GPL: Grass pollen hypersensitivity
  DIS3SD7J: Corneal abrasion
• ICD Code:
  ICD-11: ICD-11: NA06.4
  ICD-10: ICD-10: S05.0
  Expand ICD-11: 'NA06.4
  Expand ICD-10: 'S05.0

Drug-Interaction Atlas (DIA) of This Disease

This Disease is Treated as An Indication in 12 Approved Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Bacitracin	DM5OHYE	Approved	Small molecular drug	[1]
Cortisone Acetate	DMG8K57	Approved	Small molecular drug	[2]
Dexamethasone	DMMWZET	Approved	Small molecular drug	[3]
Dromostanolone	DMF2JDG	Approved	Small molecular drug	[4]
Fluorometholone	DM2HKC4	Approved	Small molecular drug	[5]
Framycetin	DMF8DNE	Approved	Small molecular drug	[6]
Fusidic Acid	DMWVCF3	Approved	Small molecular drug	[7]
Hydrocortisone	DMGEMB7	Approved	Small molecular drug	[8]
Medrysone	DMJ90O5	Approved	Small molecular drug	[9]
Polymyxin B Sulfate	DMN0LP8	Approved	Small molecular drug	[10]
Prednisolone	DMQ8FR2	Approved	Small molecular drug	[11]
Tobramycin	DMUI0CH	Approved	Small molecular drug	[12]

This Disease is Treated as An Indication in 2 Investigative Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
EncorStat	DM41YJN	Investigative	NA	[13]
Recombinant galectin-3	DMUNTBH	Investigative	NA	[13]

Molecular Interaction Atlas (MIA) of This Disease

References

• [1] Bacitracin FDA Label
• [2] Cortisone acetate FDA Label
• [3] Dexamethasone FDA Label
• [4] Dromostanolone FDA Label
• [5] Fluorometholone FDA Label
• [6] A standard database for drug repositioning. Sci Data. 2017 Mar 14;4:170029.
• [7] Antibiotic prophylaxis for corneal abrasion. Cochrane Database Syst Rev. 2022 May 27;5(5):CD014617.
• [8] Hydrocortisone FDA Label
• [9] Medrysone FDA Label
• [10] Polymyxin B Sulfate FDA Label
• [11] Prednisolone FDA Label
• [12] Tobramycin FDA Label
• [13] The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.